대장암 검진 시장 보고서(2026년)

Colorectal cancer screening refers to testing procedures aimed at detecting early signs of colorectal cancer before symptoms manifest. Early detection through screening can identify precancerous polyps or cancer at a more treatable stage, significantly enhancing patient outcomes. Screening is recommended for adults starting at age 45, or earlier for those at higher risk.

The primary types of colorectal cancer screening include stool-based tests, fecal immunochemical tests (FIT), fecal occult blood tests (FOBT), stool deoxyribonucleic acid (DNA) tests, and colonoscopy, among others. Stool-based colorectal cancer screening involves analyzing a stool sample for indicators of cancer-related substances or abnormalities, such as blood or DNA mutations, to identify potential colorectal cancer. These screenings are categorized by age groups, including individuals under 50, those aged 50-64, and those over 65. The end users of these tests encompass hospitals and clinics, clinical laboratories, diagnostic imaging centers, and other healthcare providers.

Tariffs are impacting the colorectal cancer screening market by increasing costs of imported diagnostic devices, endoscopy equipment, imaging components, reagents, and test kits used in screening procedures. Hospitals, diagnostic laboratories, and imaging centers in North America and Europe are most affected due to reliance on imported medical devices, while Asia-Pacific faces higher costs for equipment manufacturing and distribution. These tariffs are increasing procedural costs and delaying equipment upgrades. However, they are also encouraging domestic production of diagnostic kits, local manufacturing of screening devices, and regional supply chain strengthening.

The colorectal cancer screening market research report is one of a series of new reports from The Business Research Company that provides colorectal cancer screening market statistics, including colorectal cancer screening industry global market size, regional shares, competitors with a colorectal cancer screening market share, detailed colorectal cancer screening market segments, market trends and opportunities, and any further data you may need to thrive in the colorectal cancer screening industry. This colorectal cancer screening market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The colorectal cancer screening market size has grown strongly in recent years. It will grow from $16.56 billion in 2025 to $17.56 billion in 2026 at a compound annual growth rate (CAGR) of 6.1%. The growth in the historic period can be attributed to rising prevalence of colorectal cancer, expansion of national screening guidelines, increasing awareness of early diagnosis benefits, adoption of fecal-based screening methods, improved access to diagnostic services.

The colorectal cancer screening market size is expected to see strong growth in the next few years. It will grow to $22.06 billion in 2030 at a compound annual growth rate (CAGR) of 5.9%. The growth in the forecast period can be attributed to increasing screening uptake among younger populations, growing integration of AI in endoscopy procedures, expansion of telehealth-supported screening programs, rising focus on personalized cancer risk assessment, increasing investments in preventive healthcare infrastructure. Major trends in the forecast period include increasing adoption of non-invasive screening tests, rising use of AI-assisted colonoscopy systems, growing demand for home-based stool testing kits, expansion of population-wide screening programs, enhanced focus on early detection and preventive care.

The increasing aging population is projected to drive the growth of the colorectal cancer screening market in the coming years. An aging population refers to a demographic trend characterized by a rising proportion of elderly individuals (typically those aged 65 and older) relative to the working-age population, often resulting from longer life expectancies and declining birth rates. As life expectancies increase and birth rates decline, the share of older adults in the global population continues to grow. Colorectal cancer screening plays a crucial role in addressing the needs of this expanding aging population by enabling early detection and preventive measures, which are essential for managing the heightened cancer risk among older adults and improving their overall health outcomes. For example, in January 2024, data from the Population Reference Bureau (PRB), a U.S.-based nonprofit research organization, projected that the number of Americans aged 65 and older would rise from 58 million in 2022 to 82 million by 2050, representing a 47% increase. Additionally, their share of the total population is expected to grow from 17% to 23%. Thus, the increasing aging population is a significant driver of the colorectal cancer screening market.

Key players in the colorectal cancer screening market are focusing on developing innovative solutions, such as non-invasive multi-target stool ribonucleic acid (RNA) colorectal cancer screening tests, to provide accessible and effective early detection methods, thereby improving patient outcomes and promoting wider screening participation. Non-invasive multi-target stool RNA colorectal cancer screening tests evaluate RNA markers from stool samples to identify the presence of colorectal cancer or precancerous lesions, offering a non-surgical approach for early detection. For instance, in May 2024, Geneoscopy Inc., a U.S.-based life sciences company, announced that it received U.S. Food and Drug Administration (FDA) approval for ColoSense. This test utilizes RNA biomarkers for a non-invasive, stool-based screening method that demonstrated 93% sensitivity in detecting colorectal cancer and 45% sensitivity for advanced adenomas. Its significance lies in its high accuracy, particularly among younger populations, and its potential to enhance screening rates by providing a less invasive alternative to traditional methods.

In November 2023, Geneoscopy Inc. partnered with Laboratory Corporation (LabCorp), a U.S.-based life science and healthcare company, to broaden access to Geneoscopy's non-invasive multi-target stool RNA colorectal cancer screening test. This collaboration aims to improve early and sensitive detection of colorectal cancer and precancerous lesions, address health disparities, and increase screening rates by leveraging LabCorp's extensive network of healthcare providers and patients. LabCorp is known for offering colon cancer screening and diagnostic tests.

Major companies operating in the colorectal cancer screening market are F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Medtronic plc, Siemens Healthineers, FUJIFILM Holdings Corporation, GE HealthCare, Boston Scientific Corporation, Olympus Corporation, Hologic Inc., bioMerieux SA, QuidelOrtho Corporation, Sysmex Corporation, QIAGEN N.V., Exact Sciences Corporation, Guardant Health Inc., Eiken Chemical Co. Ltd., HemoCue AB, Clinical Genomics Inc., Polymedco LLC, Hemosure Inc., Geneoscopy Inc., Novigenix SA

North America was the largest region in the colorectal cancer screening market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the colorectal cancer screening market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the colorectal cancer screening market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The colorectal cancer screening market includes revenues earned by entities by providing services such as genetic and molecular testing, patient education and awareness programs, and screening result analysis. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Colorectal Cancer Screening Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses colorectal cancer screening market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for colorectal cancer screening ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The colorectal cancer screening market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Type: Stool-Based; Fecal Immunochemical Test (FIT); Fecal Occult Blood Test (FOBT); Stool Deoxyribonucleic Acid (DNA) Test; Colonoscopy; Other Types
• 2) By Age Group: Below 50 Years; 50-64 Years; Above 65 Years
• 3) By End User: Hospitals And Clinics; Clinical Laboratories; Diagnostic Imaging Centers; Other End-Users
• Subsegments:
• 1) By Stool-Based: Stool-Based Tests
• 2) By Fecal Immunochemical Test (FIT): High-Sensitivity FIT; Low-Sensitivity FIT
• 3) By Fecal Occult Blood Test (FOBT): Guaiac FOBT; Immunochemical FOBT
• 4) By Stool Deoxyribonucleic Acid (DNA) Test: Multi-Target Stool DNA Test; Single-Target Stool DNA Test
• 5) By Colonoscopy: Diagnostic Colonoscopy; Therapeutic Colonoscopy
• 6) By Other Types: Virtual Colonoscopy; Flexible Sigmoidoscopy; Capsule Endoscopy
• Companies Mentioned: F. Hoffmann-La Roche AG; Thermo Fisher Scientific Inc.; Abbott Laboratories; Medtronic plc; Siemens Healthineers; FUJIFILM Holdings Corporation; GE HealthCare; Boston Scientific Corporation; Olympus Corporation; Hologic Inc.; bioMerieux SA; QuidelOrtho Corporation; Sysmex Corporation; QIAGEN N.V.; Exact Sciences Corporation; Guardant Health Inc.; Eiken Chemical Co. Ltd.; HemoCue AB; Clinical Genomics Inc.; Polymedco LLC; Hemosure Inc.; Geneoscopy Inc.; Novigenix SA
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

• 1.1. Key Market Insights (2020-2035)
• 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
• 1.3. Major Factors Driving the Market
• 1.4. Top Three Trends Shaping the Market

2. Colorectal Cancer Screening Market Characteristics

• 2.1. Market Definition & Scope
• 2.2. Market Segmentations
• 2.3. Overview of Key Products and Services
• 2.4. Global Colorectal Cancer Screening Market Attractiveness Scoring And Analysis
  • 2.4.1. Overview of Market Attractiveness Framework
  • 2.4.2. Quantitative Scoring Methodology
  • 2.4.3. Factor-Wise Evaluation
• Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
• 2.4.4. Market Attractiveness Scoring and Interpretation
• 2.4.5. Strategic Implications and Recommendations

3. Colorectal Cancer Screening Market Supply Chain Analysis

• 3.1. Overview of the Supply Chain and Ecosystem
• 3.2. List Of Key Raw Materials, Resources & Suppliers
• 3.3. List Of Major Distributors and Channel Partners
• 3.4. List Of Major End Users

4. Global Colorectal Cancer Screening Market Trends And Strategies

• 4.1. Key Technologies & Future Trends
  • 4.1.1 Artificial Intelligence & Autonomous Intelligence
  • 4.1.2 Biotechnology, Genomics & Precision Medicine
  • 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
  • 4.1.4 Industry 4.0 & Intelligent Manufacturing
  • 4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
• 4.2. Major Trends
  • 4.2.1 Increasing Adoption Of Non-Invasive Screening Tests
  • 4.2.2 Rising Use Of AI-Assisted Colonoscopy Systems
  • 4.2.3 Growing Demand For Home-Based Stool Testing Kits
  • 4.2.4 Expansion Of Population-Wide Screening Programs
  • 4.2.5 Enhanced Focus On Early Detection And Preventive Care

5. Colorectal Cancer Screening Market Analysis Of End Use Industries

• 5.1 Hospitals And Clinics
• 5.2 Clinical Laboratories
• 5.3 Diagnostic Imaging Centers
• 5.4 Preventive Healthcare Centers
• 5.5 Public Health Screening Programs

6. Colorectal Cancer Screening Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Colorectal Cancer Screening Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

• 7.1. Global Colorectal Cancer Screening PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 7.2. Global Colorectal Cancer Screening Market Size, Comparisons And Growth Rate Analysis
• 7.3. Global Colorectal Cancer Screening Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
• 7.4. Global Colorectal Cancer Screening Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Colorectal Cancer Screening Total Addressable Market (TAM) Analysis for the Market

• 8.1. Definition and Scope of Total Addressable Market (TAM)
• 8.2. Methodology and Assumptions
• 8.3. Global Total Addressable Market (TAM) Estimation
• 8.4. TAM vs. Current Market Size Analysis
• 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Colorectal Cancer Screening Market Segmentation

• 9.1. Global Colorectal Cancer Screening Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Stool-Based, Fecal Immunochemical Test (FIT), Fecal Occult Blood Test (FOBT), Stool Deoxyribonucleic Acid (DNA) Test, Colonoscopy, Other Types
• 9.2. Global Colorectal Cancer Screening Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Below 50 Years, 50-64 Years, Above 65 Years
• 9.3. Global Colorectal Cancer Screening Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Hospitals And Clinics, Clinical Laboratories, Diagnostic Imaging Centers, Other End-Users
• 9.4. Global Colorectal Cancer Screening Market, Sub-Segmentation Of Stool-Based, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Stool-Based Tests
• 9.5. Global Colorectal Cancer Screening Market, Sub-Segmentation Of Fecal Immunochemical Test (FIT), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• High-Sensitivity FIT, Low-Sensitivity FIT
• 9.6. Global Colorectal Cancer Screening Market, Sub-Segmentation Of Fecal Occult Blood Test (FOBT), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Guaiac FOBT, Immunochemical FOBT
• 9.7. Global Colorectal Cancer Screening Market, Sub-Segmentation Of Stool Deoxyribonucleic Acid (DNA) Test, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Multi-Target Stool DNA Test, Single-Target Stool DNA Test
• 9.8. Global Colorectal Cancer Screening Market, Sub-Segmentation Of Colonoscopy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Diagnostic Colonoscopy, Therapeutic Colonoscopy
• 9.9. Global Colorectal Cancer Screening Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Virtual Colonoscopy, Flexible Sigmoidoscopy, Capsule Endoscopy

10. Colorectal Cancer Screening Market, Industry Metrics By Country

• 10.1. Global Colorectal Cancer Screening Market, Average Selling Price By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $
• 10.2. Global Colorectal Cancer Screening Market, Average Spending Per Capita (Employed) By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $

11. Colorectal Cancer Screening Market Regional And Country Analysis

• 11.1. Global Colorectal Cancer Screening Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• 11.2. Global Colorectal Cancer Screening Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. Asia-Pacific Colorectal Cancer Screening Market

• 12.1. Asia-Pacific Colorectal Cancer Screening Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 12.2. Asia-Pacific Colorectal Cancer Screening Market, Segmentation By Type, Segmentation By Age Group, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. China Colorectal Cancer Screening Market

• 13.1. China Colorectal Cancer Screening Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 13.2. China Colorectal Cancer Screening Market, Segmentation By Type, Segmentation By Age Group, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. India Colorectal Cancer Screening Market

• 14.1. India Colorectal Cancer Screening Market, Segmentation By Type, Segmentation By Age Group, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Japan Colorectal Cancer Screening Market

• 15.1. Japan Colorectal Cancer Screening Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 15.2. Japan Colorectal Cancer Screening Market, Segmentation By Type, Segmentation By Age Group, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Australia Colorectal Cancer Screening Market

• 16.1. Australia Colorectal Cancer Screening Market, Segmentation By Type, Segmentation By Age Group, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. Indonesia Colorectal Cancer Screening Market

• 17.1. Indonesia Colorectal Cancer Screening Market, Segmentation By Type, Segmentation By Age Group, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. South Korea Colorectal Cancer Screening Market

• 18.1. South Korea Colorectal Cancer Screening Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 18.2. South Korea Colorectal Cancer Screening Market, Segmentation By Type, Segmentation By Age Group, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. Taiwan Colorectal Cancer Screening Market

• 19.1. Taiwan Colorectal Cancer Screening Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 19.2. Taiwan Colorectal Cancer Screening Market, Segmentation By Type, Segmentation By Age Group, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. South East Asia Colorectal Cancer Screening Market

• 20.1. South East Asia Colorectal Cancer Screening Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 20.2. South East Asia Colorectal Cancer Screening Market, Segmentation By Type, Segmentation By Age Group, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. Western Europe Colorectal Cancer Screening Market

• 21.1. Western Europe Colorectal Cancer Screening Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 21.2. Western Europe Colorectal Cancer Screening Market, Segmentation By Type, Segmentation By Age Group, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. UK Colorectal Cancer Screening Market

• 22.1. UK Colorectal Cancer Screening Market, Segmentation By Type, Segmentation By Age Group, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. Germany Colorectal Cancer Screening Market

• 23.1. Germany Colorectal Cancer Screening Market, Segmentation By Type, Segmentation By Age Group, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. France Colorectal Cancer Screening Market

• 24.1. France Colorectal Cancer Screening Market, Segmentation By Type, Segmentation By Age Group, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Italy Colorectal Cancer Screening Market

• 25.1. Italy Colorectal Cancer Screening Market, Segmentation By Type, Segmentation By Age Group, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Spain Colorectal Cancer Screening Market

• 26.1. Spain Colorectal Cancer Screening Market, Segmentation By Type, Segmentation By Age Group, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Eastern Europe Colorectal Cancer Screening Market

• 27.1. Eastern Europe Colorectal Cancer Screening Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 27.2. Eastern Europe Colorectal Cancer Screening Market, Segmentation By Type, Segmentation By Age Group, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. Russia Colorectal Cancer Screening Market

• 28.1. Russia Colorectal Cancer Screening Market, Segmentation By Type, Segmentation By Age Group, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. North America Colorectal Cancer Screening Market

• 29.1. North America Colorectal Cancer Screening Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 29.2. North America Colorectal Cancer Screening Market, Segmentation By Type, Segmentation By Age Group, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. USA Colorectal Cancer Screening Market

• 30.1. USA Colorectal Cancer Screening Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 30.2. USA Colorectal Cancer Screening Market, Segmentation By Type, Segmentation By Age Group, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. Canada Colorectal Cancer Screening Market

• 31.1. Canada Colorectal Cancer Screening Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 31.2. Canada Colorectal Cancer Screening Market, Segmentation By Type, Segmentation By Age Group, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. South America Colorectal Cancer Screening Market

• 32.1. South America Colorectal Cancer Screening Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 32.2. South America Colorectal Cancer Screening Market, Segmentation By Type, Segmentation By Age Group, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Brazil Colorectal Cancer Screening Market

• 33.1. Brazil Colorectal Cancer Screening Market, Segmentation By Type, Segmentation By Age Group, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Middle East Colorectal Cancer Screening Market

• 34.1. Middle East Colorectal Cancer Screening Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 34.2. Middle East Colorectal Cancer Screening Market, Segmentation By Type, Segmentation By Age Group, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Africa Colorectal Cancer Screening Market

• 35.1. Africa Colorectal Cancer Screening Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 35.2. Africa Colorectal Cancer Screening Market, Segmentation By Type, Segmentation By Age Group, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

36. Colorectal Cancer Screening Market Regulatory and Investment Landscape

37. Colorectal Cancer Screening Market Competitive Landscape And Company Profiles

• 37.1. Colorectal Cancer Screening Market Competitive Landscape And Market Share 2024
  • 37.1.1. Top 10 Companies (Ranked by revenue/share)
• 37.2. Colorectal Cancer Screening Market - Company Scoring Matrix
  • 37.2.1. Market Revenues
  • 37.2.2. Product Innovation Score
  • 37.2.3. Brand Recognition
• 37.3. Colorectal Cancer Screening Market Company Profiles
  • 37.3.1. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
  • 37.3.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 37.3.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 37.3.4. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
  • 37.3.5. Siemens Healthineers Overview, Products and Services, Strategy and Financial Analysis

38. Colorectal Cancer Screening Market Other Major And Innovative Companies

• FUJIFILM Holdings Corporation, GE HealthCare, Boston Scientific Corporation, Olympus Corporation, Hologic Inc., bioMerieux SA, QuidelOrtho Corporation, Sysmex Corporation, QIAGEN N.V., Exact Sciences Corporation, Guardant Health Inc., Eiken Chemical Co. Ltd., HemoCue AB, Clinical Genomics Inc., Polymedco LLC

39. Global Colorectal Cancer Screening Market Competitive Benchmarking And Dashboard

40. Key Mergers And Acquisitions In The Colorectal Cancer Screening Market

41. Colorectal Cancer Screening Market High Potential Countries, Segments and Strategies

• 41.1. Colorectal Cancer Screening Market In 2030 - Countries Offering Most New Opportunities
• 41.2. Colorectal Cancer Screening Market In 2030 - Segments Offering Most New Opportunities
• 41.3. Colorectal Cancer Screening Market In 2030 - Growth Strategies
  • 41.3.1. Market Trend Based Strategies
  • 41.3.2. Competitor Strategies

42. Appendix

• 42.1. Abbreviations
• 42.2. Currencies
• 42.3. Historic And Forecast Inflation Rates
• 42.4. Research Inquiries
• 42.5. The Business Research Company
• 42.6. Copyright And Disclaimer